However, as the difference of 3PG and PEP between AD and non-AD patients is highly significant, we want to point to the applicability of metabolome analysis in the diagnostic process of neurodegenerative diseases.
← all excerpts
Reduction of Glycolysis Intermediate Concentrations in the Cerebrospinal Fluid of Alzheimer's Disease Patients.
1
—
—